先后在中国药科大学药剂学（本科、硕士）、药代动力学（博士），北京大学（博士后）学习，

主持企业项目五十余项，主持科技部重大专项、国家自然基金委、教育部、江苏省科技厅、江苏省教育厅、江苏省人才办项目十余项，在缓控释制剂、固体制剂方向产业化经验丰富，擅长制剂一致性评价工艺研究，与国内外数十家企业合作，主持一类创新药西达本胺片药学研究（2014年获得新药证书），在美国进入2期临床），获得20余个新药证书或者临床批件

1、Lifang Yin*,Chao Qin, Kaisheng Chen, Chunli Zhu, Cao Hui, Jianping Zhou WeiHe*,Qiang Zhang*. Gastro-floating tablets of cephalexin: Preparation and invitro/in vivo evaluation, Int J Pharm., 2013, 452(1-2): 241-248.
2、Qin C, He B, Dai W, Lin Z, Zhang H, Wang Q, Wang J, Zhang X, Wang G*, Yin L*, Zhang Q*. The impact of a chlorotoxin modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3. Biomaterials. 2014, 35(22):5908-20.
3、Yongji Li,Zhannan Wu,Wei He,*Chao Qin,Jing Yao,Jianping Zhou and Lifang Yin *, Globular Protein-Coated Paclitaxel Nanosuspensions: Interaction Mechanism, Direct Cytosolic Delivery, and Significant Improvement in Pharmacokinetics, Mol. Pharmaceutics 2015, 12, 1485-1500
4、Wei He,Mengmeng Wu,Shijing Huang, Lifang Yin*. Matrix tablets for sustained release of repaglinide: Preparation, pharmacokinetics and hypoglycemic activity in beagle dogs,Int J Pharm., 2015,478 ,297-307
5、Qin C, He W, Zhu C, Wu M, Jin Z, Zhang Q, Wang G, Yin L*. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int J Pharm.2014, 466,276–285.

以第一发明人申请发明专利40余项，获得授权7项，专利权转让3项